The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies

标题
The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies
作者
关键词
-
出版物
CURRENT OPINION IN BIOTECHNOLOGY
Volume 20, Issue 6, Pages 722-729
出版商
Elsevier BV
发表日期
2009-11-07
DOI
10.1016/j.copbio.2009.10.013

向作者/读者发起求助以获取更多资源

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now